JP7291782B2 - ３－［５－アミノ－４－（３－シアノベンゾイル）－ピラゾール化合物の調製のための合成方法 - Google Patents

３－［５－アミノ－４－（３－シアノベンゾイル）－ピラゾール化合物の調製のための合成方法 Download PDF

Info

Publication number
JP7291782B2
JP7291782B2 JP2021516883A JP2021516883A JP7291782B2 JP 7291782 B2 JP7291782 B2 JP 7291782B2 JP 2021516883 A JP2021516883 A JP 2021516883A JP 2021516883 A JP2021516883 A JP 2021516883A JP 7291782 B2 JP7291782 B2 JP 7291782B2
Authority
JP
Japan
Prior art keywords
compound
reaction mass
optionally
reaction
aprotic solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021516883A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022502400A5 (enExample
JP2022502400A (ja
Inventor
マイゼンバッハ，マルク
マーティン，ベンジャミン
ヨハネス ロンデ，ニーク
ルイス，カルメン
Original Assignee
メレオ バイオファーマ １ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メレオ バイオファーマ １ リミテッド filed Critical メレオ バイオファーマ １ リミテッド
Publication of JP2022502400A publication Critical patent/JP2022502400A/ja
Publication of JP2022502400A5 publication Critical patent/JP2022502400A5/ja
Application granted granted Critical
Publication of JP7291782B2 publication Critical patent/JP7291782B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10—Hydrazines
    • C07C243/22—Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2021516883A 2018-09-26 2019-09-26 ３－［５－アミノ－４－（３－シアノベンゾイル）－ピラゾール化合物の調製のための合成方法 Active JP7291782B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1815695.0A GB201815695D0 (en) 2018-09-26 2018-09-26 Synthetic method
GB1815695.0 2018-09-26
PCT/GB2019/052718 WO2020065323A1 (en) 2018-09-26 2019-09-26 Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound

Publications (3)

Publication Number Publication Date
JP2022502400A JP2022502400A (ja) 2022-01-11
JP2022502400A5 JP2022502400A5 (enExample) 2022-12-14
JP7291782B2 true JP7291782B2 (ja) 2023-06-15

Family

ID=64024269

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021516883A Active JP7291782B2 (ja) 2018-09-26 2019-09-26 ３－［５－アミノ－４－（３－シアノベンゾイル）－ピラゾール化合物の調製のための合成方法

Country Status (12)

Country Link
US (1) US11649213B2 (enExample)
EP (1) EP3856721B1 (enExample)
JP (1) JP7291782B2 (enExample)
KR (1) KR102711257B1 (enExample)
CN (1) CN112839928B (enExample)
AU (1) AU2019350525B2 (enExample)
CA (1) CA3112993A1 (enExample)
DK (1) DK3856721T3 (enExample)
ES (1) ES2943289T3 (enExample)
GB (1) GB201815695D0 (enExample)
IL (1) IL281636B2 (enExample)
WO (1) WO2020065323A1 (enExample)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007521278A (ja) 2003-06-26 2007-08-02 ノバルティス アクチエンゲゼルシャフト ５員ヘテロ環を基礎とするｐ３８キナーゼ阻害剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1809386A1 (de) 1968-11-16 1970-06-11 Bayer Ag Verfahren zur Herstellung von 1,5-disubstituierten 4-Cyanopyrazolen
US4686221A (en) * 1985-10-01 1987-08-11 Kanebo, Ltd. Quinolinecarboxylic acid compounds and antimicrobial agent containing the same
US6005109A (en) * 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
US6103900A (en) * 1992-12-17 2000-08-15 Pfizer Inc Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
FR2732967B1 (fr) 1995-04-11 1997-07-04 Sanofi Sa 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
PL344004A1 (en) * 1998-05-05 2001-09-10 Hoffmann La Roche Pyrazole derivatives as p-38 map kinase inhibitors
WO2005007632A1 (en) 2003-07-18 2005-01-27 Pharmacia Corporation Substituted pyridazinones as inhibitors of p38
US7485657B2 (en) * 2004-05-12 2009-02-03 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
WO2007083320A2 (en) 2006-01-19 2007-07-26 Matrix Laboratories Ltd Conversion of aromatic diazonium salt to aryl hydrazine
US20100292290A1 (en) 2007-08-02 2010-11-18 Vinayak Gore Novel process to prepare almotriptan
CN101910139B (zh) 2008-01-10 2012-09-26 北兴化学工业株式会社 苯基三唑啉酮类的制造方法
JP5602387B2 (ja) 2008-05-02 2014-10-08 キヤノン株式会社 インクジェット用インク、インクジェット記録方法、インクカートリッジ、記録ユニット、及びインクジェット記録装置
CN102964270B (zh) 2012-11-21 2015-01-07 合肥星宇化学有限责任公司 一种亚硫酸钠还原重氮盐合成肼的方法
WO2018059533A1 (zh) * 2016-09-29 2018-04-05 南京明德新药研发股份有限公司 p38αMAPK激酶抑制剂及其制备方法和应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007521278A (ja) 2003-06-26 2007-08-02 ノバルティス アクチエンゲゼルシャフト ５員ヘテロ環を基礎とするｐ３８キナーゼ阻害剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARKIVOC，2017年，part ii，pp.446-456

Also Published As

Publication number Publication date
EP3856721B1 (en) 2023-03-29
CN112839928B (zh) 2024-04-30
US20210395207A1 (en) 2021-12-23
IL281636B1 (en) 2024-04-01
DK3856721T3 (da) 2023-04-24
KR102711257B1 (ko) 2024-09-30
CN112839928A (zh) 2021-05-25
EP3856721A1 (en) 2021-08-04
ES2943289T3 (es) 2023-06-12
CA3112993A1 (en) 2020-04-02
IL281636A (en) 2021-05-31
KR20210069044A (ko) 2021-06-10
AU2019350525A1 (en) 2021-04-15
WO2020065323A1 (en) 2020-04-02
JP2022502400A (ja) 2022-01-11
AU2019350525B2 (en) 2024-05-02
GB201815695D0 (en) 2018-11-07
IL281636B2 (en) 2024-08-01
US11649213B2 (en) 2023-05-16

Similar Documents

Publication Publication Date Title
JP2009167166A (ja) ピペラジン誘導体の製造方法
WO2012176717A1 (ja) ピラゾール化合物の製造方法
DK2468716T3 (en) PROCEDURE FOR THE PREPARATION OF BENDAMUSTIN ALKYL ESTERS, BENDAMUSTIN AND DERIVATIVES OF SAME
KR102711257B1 (ko) 3-[5-아미노-4-(3-시아노벤조일)-피라졸 화합물의 제조를 위한 합성 방법
EP3856711B1 (en) Synthetic method for the preparation of an hydrazine compound
EP3856712B1 (en) Synthetic methodfor the preparation of an alkoxymethylene-benzoylacetonitrile
WO2015097850A1 (ja) ２－アミノニコチン酸ベンジルエステル誘導体の製造方法
HK40049030A (en) Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound
HK40049030B (en) Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound
JP2013006782A (ja) ピラゾール化合物の製造方法
JP5915004B2 (ja) ピラゾール化合物の製造方法
JP4126944B2 (ja) ５−アミノ−４−ニトロソピラゾール化合物の製法
WO2007090464A1 (en) Process for preparing letrozole
JP4267943B2 (ja) ３−アミノ−４−置換−５−ピラゾロン類の製造方法
JPH05140121A (ja) １，２，３−トリアゾールの製法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220613

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221206

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20221206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230131

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230425

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230523

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230605

R150 Certificate of patent or registration of utility model

Ref document number: 7291782

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150